These results suggest that the altered cannabinoid CB1 and CB2 responsiveness is maintained long after an initial inflammatory period and suggest a role of cannabinoid receptors in the underlying pathophysiology of PI-IBS. This evidence concerns the gene CNR1 and irritable bowel syndrome.